KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) Interest Expenses (2016 - 2022)

Biolife Solutions (BLFS) has disclosed Interest Expenses for 12 consecutive years, with $6.7 million as the latest value for Q4 2022.

  • Quarterly Interest Expenses rose 458.33% to $6.7 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2022, up 458.33% year-over-year, with the annual reading at $6.7 million for FY2022, 458.33% up from the prior year.
  • Interest Expenses for Q4 2022 was $6.7 million at Biolife Solutions, up from $1.2 million in the prior quarter.
  • The five-year high for Interest Expenses was $6.7 million in Q4 2022, with the low at -$9000.0 in Q4 2020.
  • Average Interest Expenses over 5 years is $720363.6, with a median of $4000.0 recorded in 2020.
  • The sharpest move saw Interest Expenses plummeted 99.04% in 2018, then skyrocketed 13433.33% in 2021.
  • Over 5 years, Interest Expenses stood at $1000.0 in 2018, then skyrocketed by 1200.0% to $13000.0 in 2019, then crashed by 169.23% to -$9000.0 in 2020, then surged by 13433.33% to $1.2 million in 2021, then surged by 458.33% to $6.7 million in 2022.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $6.7 million, $1.2 million, and $7000.0 for Q4 2022, Q4 2021, and Q3 2021 respectively.